Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Vir Biotechnology, Inc. (VIR)
|
Add to portfolio |
|
|
|
| Price: |
$37.11
| | Metrics |
| OS: |
134.3
|
M
| |
-14
|
% ROE
|
| Market cap: |
$4.98
|
B
| |
-19
|
% ROIC
|
|
Net cash:
|
$1.89
|
B
| |
$14.05
|
per share
|
|
EV:
|
$3.1
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
($268)
|
M
| |
|
|
| EPS |
($1.97)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Revenues | 1,615.8 | 1,095.4 | 1,095.4 | 76.4 | 8.1 | 10.7 | 2.7 |
| Revenue growth | 47.5% | 1334.4% | | 843.9% | -24.2% | 293.9% | |
| Cost of goods sold | 621.0 | 674.7 | 513.9 | 373.3 | 186.1 | 0.0 | 0.0 |
| Gross profit | 994.8 | 420.8 | 581.5 | -297.0 | -178.0 | 10.7 | 2.7 |
| Gross margin | 61.6% | 38.4% | 53.1% | -388.9% | -2199.7% | 100.0% | 100.0% |
| Selling, general and administrative | 161.8 | 0.0 | 160.8 | 0.0 | 0.0 | | |
| Research and development | | | | | | 100.2 | 62.5 |
| General and administrative | | 0.0 | | 0.0 | 0.0 | 29.1 | 21.7 |
| EBITA | 833.1 | 679.4 | 420.8 | -295.9 | -174.7 | -117.6 | -81.3 |
| EBITA margin | 51.6% | 62.0% | 38.4% | -387.5% | -2159.3% | -1101.9% | -3003.0% |
| Amortization of intangibles | | 0.5 | | 1.0 | 1.2 | 1.1 | 0.2 |
| EBIT | 833.1 | 678.9 | 420.8 | -297.0 | -175.9 | -118.7 | -81.5 |
| EBIT margin | 51.6% | 62.0% | 38.4% | -388.9% | -2174.4% | -1112.6% | -3009.5% |
| Pre-tax income | 754.3 | 549.8 | 549.8 | -298.6 | -174.5 | -116.4 | -80.8 |
| Income taxes | 238.4 | 21.2 | 21.2 | 0.1 | 0.2 | -0.5 | -10.9 |
| Tax rate | 31.6% | 3.9% | 3.9% | | | 0.4% | 13.5% |
| Net income | 515.8 | 528.6 | 528.6 | -298.7 | -174.7 | -115.9 | -69.9 |
| Net margin | 31.9% | 48.3% | 48.3% | -391.1% | -2159.0% | -1086.3% | -2579.5% |
| |
| Diluted EPS | $3.83 | $3.96 | $3.96 | ($2.51) | ($5.76) | ($15.12) | ($32.45) |
| Shares outstanding (diluted) | 134.8 | 133.4 | 133.4 | 119.2 | 30.3 | 7.7 | 2.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|